(Q36688354)

15 August 2017

1 reference

title

The changing costs and benefits of screening for asymptomatic coronary heart disease in patients with diabetes (English)

1 reference

15 August 2017

1 reference

coronary artery disease

1 reference

1

Martin K Rutter

1 reference

15 August 2017

Richard W Nesto

2

1 reference

15 August 2017

1 January 2007

1 reference

Nature Clinical Practice Endocrinology and Metabolism

15 August 2017

1 reference

15 August 2017

3

1 reference

15 August 2017

26-35

1 reference

15 August 2017

1

1 reference

Perfusion thallium imaging of type I diabetes patients with end stage renal disease: comparison of oral and intravenous dipyridamole administration

15 August 2017

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

Exercise tolerance testing to screen for coronary heart disease: a systematic review for the technical support for the U.S. Preventive Services Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevention Conference VI: Diabetes and Cardiovascular Disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Predictive value of clinical and exercise variables for detection of coronary artery disease in men with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Diagnostic and prognostic value of vasodilator stress echocardiography in asymptomatic Type 2 diabetic patients with positive exercise thallium scintigraphy: a pilot study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

High incidence of silent myocardial ischemia in elderly patients with non insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Significance of silent ischemia and microalbuminuria in predicting coronary events in asymptomatic patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevalence and prognostic value of perfusion defects detected by stress technetium-99m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prediction of coronary artery disease in a population of insulin-requiring diabetic patients: Results of an 8-year follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

The exercise test in diabetic patients as studied by radioelectrocardiography

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Exercise testing with myocardial scintigraphy in asymptomatic diabetic males

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Asymptomatic myocardial ischemia in diabetes and its relationship to diabetic neuropathy: an exercise electrocardiography study in middle-aged diabetic men

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

The significance of repeated exercise testing with thallium-201 scanning in asymptomatic diabetic males

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Predictive value of quantitative dipyridamole-thallium scintigraphy in assessing cardiovascular risk after vascular surgery in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevalence of asymptomatic myocardial ischaemia in diabetic subjects

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent myocardial ischemia and infarction in diabetics with peripheral vascular disease: assessment by dipyridamole thallium-201 scintigraphy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Detection of silent myocardial ischemia in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent ischaemia in diabetic men with autonomic neuropathy

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent myocardial ischemia in patients with non-insulin-dependent diabetes mellitus as judged by treadmill exercise testing and coronary angiography

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevalence of unrecognized silent myocardial ischemia and its association with atherosclerotic risk factors in noninsulin-dependent diabetes mellitus. Milan Study on Atherosclerosis and Diabetes (MiSAD) Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevalence and prediction of silent ischaemia in diabetes mellitus: a population-based study.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Dobutamine stress echocardiography: false positive scans in proteinuric patients with type 1 diabetes mellitus at high risk of ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent myocardial ischemia in patients with diabetes: who to screen

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent myocardial ischemia and microalbuminuria in asymptomatic subjects with non-insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Inducible myocardial ischaemia in asymptomatic Type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Dobutamine stress echocardiography response of asymptomatic patients with diabetes

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Use of dobutamine stress echocardiography in detecting silent myocardial ischaemia in asymptomatic diabetic patients: a comparison with thallium scintigraphy and exercise testing

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Cardiac tests in asymptomatic type 2 diabetics.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

The role of dobutamine stress echocardiography in detecting severe coronary artery disease in asymptomatic at high risk type 2 diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Screening for silent myocardial ischaemia in type 2 diabetic patients with additional atherogenic risk factors: applicability and accuracy of the exercise stress test

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Cardiac events in 735 type 2 diabetic patients who underwent screening for unknown asymptomatic coronary heart disease: 5-year follow-up report from the Milan Study on Atherosclerosis and Diabetes (MiSAD)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Are silent coronary stenoses predictable in diabetic patients and predictive of cardiovascular events?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Silent coronary artery disease in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Frequency of silent myocardial ischemia in type 2 diabetic patients and the relation with poor glycemic control

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Detecting silent coronary stenoses and stratifying cardiac risk in patients with diabetes: ECG stress test or exercise myocardial scintigraphy?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prognostic relevance of symptoms versus objective evidence of coronary artery disease in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Risk factors for silent myocardial ischemia in high-risk type 1 diabetic patients.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevalence of silent myocardial ischemia in persons with diabetes mellitus or impaired glucose tolerance and association of hemoglobin A1c with prevalence of silent myocardial ischemia

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Identifying high-risk asymptomatic diabetic patients who are candidates for screening stress single-photon emission computed tomography imaging.

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Coronary artery disease is common in nonuremic, asymptomatic type 1 diabetic islet transplant candidates

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Screening asymptomatic diabetic patients for coronary artery disease prior to renal transplantation

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Consensus development conference on the diagnosis of coronary heart disease in people with diabetes: 10-11 February 1998, Miami, Florida. American Diabetes Association

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Impact of diabetes on the risk stratification using stress single-photon emission computed tomography myocardial perfusion imaging in patients with symptoms suggestive of coronary artery disease

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Determinants of risk and its temporal variation in patients with normal stress myocardial perfusion scans: what is the warranty period of a normal scan?

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Coronary revascularisation in insulin-dependent diabetic patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines).

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

ACC/AHA/ASNC guidelines for the clinical use of cardiac radionuclide imaging--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASNC Committee to Revise the 1995 G

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Screening for coronary heart disease: recommendation statement

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Incremental prognostic value of myocardial perfusion single photon emission computed tomography in patients with diabetes mellitus

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Prognostic value of a negative stress echocardiographic study in diabetic patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Asymptomatic Cardiac Ischemia Pilot study (ACIP)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Effects of treatment on outcome in mildly symptomatic patients with ischemia during daily life. The Atenolol Silent Ischemia Study (ASIST)

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Usefulness of beta-blocker therapy in patients with non-insulin-dependent diabetes mellitus and coronary artery disease. Bezafibrate Infarction Prevention (BIP) Study Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPENDMET0352

7 January 2021

Identifiers

DOI

10.1038/NCPENDMET0352

1 reference

15 August 2017

1 reference

PubMed ID

17179927